SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $363,000 | -23.7% | 6,389 | +0.4% | 0.02% | -28.1% |
Q1 2021 | $476,000 | -13.1% | 6,362 | +0.5% | 0.03% | -15.8% |
Q4 2020 | $548,000 | +40.5% | 6,330 | -0.8% | 0.04% | +40.7% |
Q3 2020 | $390,000 | -34.7% | 6,379 | +49.9% | 0.03% | -18.2% |
Q3 2019 | $597,000 | -25.7% | 4,255 | -3.0% | 0.03% | -25.0% |
Q2 2019 | $803,000 | +36.1% | 4,387 | +18.2% | 0.04% | +41.9% |
Q1 2019 | $590,000 | +81.0% | 3,712 | +9.1% | 0.03% | +72.2% |
Q4 2018 | $326,000 | -18.9% | 3,403 | +19.6% | 0.02% | +5.9% |
Q3 2018 | $402,000 | – | 2,845 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
RA Capital Management | 455,173 | $74,972,000 | 6.27% |
Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |